Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Sep;31(9):4016-4026.
doi: 10.1007/s00167-023-07445-5. Epub 2023 May 12.

Multimodal analgesia did not improve post-operative pain scores, reduce opioid consumption or reduce length of stay following hip arthroscopy

Affiliations
Randomized Controlled Trial

Multimodal analgesia did not improve post-operative pain scores, reduce opioid consumption or reduce length of stay following hip arthroscopy

Ryan M Degen et al. Knee Surg Sports Traumatol Arthrosc. 2023 Sep.

Abstract

Purpose: To determine whether different regimens of multimodal analgesia will reduce postoperative pain scores, opioid consumption, costs and hospital length-of-stay following hip arthroscopy.

Methods: From 2018 to 2021, 132 patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) were included in this prospective, single-center randomized controlled trial. Patients were randomized into four treatment groups: (1) Group 1-Control: opioid medication (oxycodone-acetaminophen 5 mg/325 mg, 1-2 tabs q6H as needed), Heterotopic ossification prophylaxis-Naprosyn 500 mg twice daily × 3 weeks); (2) Group 2-Control + postoperative sleeping aid (Zopiclone 7.5 mg nightly × 7 days); (3) Group 3-Control + preoperative and postoperative Gabapentin (600 mg orally, 1 h preoperatively; 600 mg postoperatively, 8 h following pre-op dose); (4) Group 4-Control + pre-medicate with Celecoxib (400 mg orally, 1 h preoperatively) The primary outcome was pain measured with a visual analog scale, monitored daily for the first week and every other day for 6 weeks. Secondary outcomes included opioid consumption, healthcare resource use, and hospital length of stay.

Results: Patient characteristics were similar between groups. There were no statistically significant differences in pain scores between groups at any timepoint after adjusting for intra-operative traction time, intra-operative opioid administration and preoperative pain scores (p > 0.05). There were also no significant differences in the number of days that opioids were taken (n.s.) and the average daily morphine milligram equivalents consumed (n.s.). Similarly, there were no statistically significant differences in length of stay in the experimental groups, compared with the control group (n.s.). Finally, there were no differences in cost between groups (n.s.).

Conclusion: The routine use of Zopiclone, Celecoxib and Gabapentin did not improve postoperative pain control or reduce length-of-stay following hip arthroscopy. Therefore, these medications are not recommended for routine postoperative pain control following hip arthroscopy.

Level of evidence: l.

Keywords: Hip arthroscopy; Multimodal analgesia; Opioid; Pain.

PubMed Disclaimer

Similar articles

Cited by

References

References:

    1. Abebe MM, Arefayne NR, Temesgen MM, Admass BA (2022) Evidence-based perioperative pain management protocol for day case surgery in a resource limited setting: systematic review. Ann Med Surg. https://doi.org/10.1016/j.amsu.2022.104322 - DOI
    1. Acuña AJ, Jella TK, Samuel LT, Cwalina TB, Kim TS, Kamath AF (2021) A work in progress: national opioid prescription reductions across orthopaedic subspecialties in a contemporary medicare sample of 5,026,911 claims. J Am Acad Orthop Surg Glob Res Rev 5:1–12. https://doi.org/10.5435/JAAOSGlobal-D-21-00080 - DOI
    1. Bronstone AB, Leonardi C, Kubilay T, Plessl DS, Morreale PJ, Tortorich GM, Krause PC (2022) Dramatic reduction in opioid prescribing for common outpatient orthopaedic lower extremity surgical procedures at a Louisiana University-Based Safety-Net Hospital after enactment of opioid-limiting state legislation. J Am Acad Orthop Surg 30:e405–e414. https://doi.org/10.5435/JAAOS-D-21-00390 - DOI - PubMed
    1. Cunningham DJ, George SZ, Lewis BD (2020) The impact of state level public policy, prescriber education, and patient factors on opioid prescribing in elective orthopedic surgery: findings from a tertiary, academic setting. Mayo Clin Proc Innov Qual Outcomes 5:23–34 - DOI - PubMed - PMC
    1. Cunningham DJ, Kwon NF, Allen NB, Hanselman AM, Adams SB (2021) Time and state legislation have decreased opioid prescribing in elective foot and ankle surgery in the United States. Foot Ankle Spec. https://doi.org/10.1177/19386400211043361 - DOI - PubMed

Publication types